Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e971-e978
DOI: 10.1210/clinem/dgad246 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.05.2023. Verfasst von Amarens van der Vaart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, the Nether…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Fibroblast Growth Factor-23. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Public-Private Partnership TKI Agri & Food, Dutch dairy company Friesland Campina, University Medical Center Groningen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The phosphate-regulating hormone fibroblast growth factor 23 (FGF23) has been linked to deregulations in glucose metabolism, but its role is insufficiently understood.
Objective
This study investigates potential crosstalk between FGF23 and glucose homeostasis.
Methods
First, we investigated the effect of glucose loading on plasma C-terminal FGF23 levels and its temporal relationship with changes in plasma phosphate in 45 overweight (body mass index [BMI] 25-30) individuals using time-lag analyses. Second, we studied cross-sectional associations of plasma C-terminal FGF23 levels with glucose homeostasis using multivariable linear regression in a population-based cohort. We also investigated associations of FGF23 with incident diabetes and obesity (BMI > 30) in individuals without diabetes or obesity at baseline, respectively, using multivariable Cox regression analyses. Finally, we explored whether the association between FGF23 and diabetes depends on BMI.
Results
After glucose loading, changes in FGF23 preceded changes in plasma phosphate (Ptime-lag = .04). In the population-based cohort (N = 5482; mean age 52 years, 52% women, median FGF23 69 RU/mL), FGF23 was associated with plasma glucose (β = .13 [.03-.23]; P = .01), insulin (β = .10 [.03-.17]; P < .001), and proinsulin (β = .06 [0.02-0.10]; P = .01) at baseline. On longitudinal analyses, a higher baseline FGF23 was independently associated with development of diabetes (199 events [4%]; fully adjusted hazard ratio [HR] 1.66 [95% CI, 1.06-2.60]; P = .03) and development of obesity (241 events [6%]; fully adjusted HR 1.84 [95% CI, 1.34-2.50]; P < .001). The association between FGF23 and incident diabetes lost significance after additional adjustment for BMI.
Conclusion
Glucose loading has phosphate-independent effects on FGF23 and, vice versa, FGF23 is associated with glucose, insulin and proinsulin levels, and obesity. These findings suggest crosstalk between FGF23 and glucose homeostasis, which may promote susceptibility to incident diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, the Netherlands.
- Department of Endocrinology, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, the Netherlands.
ORCID-Profile: Amarens van der Vaart, Coby Eelderink
Förderung
- Public-Private Partnership TKI Agri & Food
- Dutch dairy company Friesland Campina
- University Medical Center Groningen
Zitieren
APA
van der Vaart, A., Eelderink, C., van Beek, A. P., Bakker, S. J. L., van Dijk, P. R., & de Borst, M. H. (2023). Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies. The Journal of Clinical Endocrinology & Metabolism, 108(10), e971-e978. https://doi.org/10.1210/clinem/dgad246
Vancouver
van der Vaart A, Eelderink C, van Beek AP, Bakker SJL, van Dijk PR, de Borst MH. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e971-e978. doi:10.1210/clinem/dgad246
BibTeX
@article{vanderVaart2023,
author = {van der Vaart, Amarens and Eelderink, Coby and van Beek, André P and Bakker, Stephan J L and van Dijk, Peter R and de Borst, Martin H},
title = {Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {10},
pages = {e971--e978},
doi = {10.1210/clinem/dgad246}
}
EUVIMED